These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23529812)

  • 1. New applications of phospholipid vesicle-based permeation assay: permeation model mimicking skin barrier.
    Engesland A; Skar M; Hansen T; Škalko-Basnet N; Flaten GE
    J Pharm Sci; 2013 May; 102(5):1588-600. PubMed ID: 23529812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro models to estimate drug penetration through the compromised stratum corneum barrier.
    Engesland A; Škalko-Basnet N; Flaten GE
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1742-51. PubMed ID: 27019078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of phospholipid vesicle-based permeation assay models capable of evaluating percutaneous penetration enhancing effect.
    Ma M; Di HJ; Zhang H; Yao JH; Dong J; Yan GJ; Qiao HZ; Chen J
    Drug Dev Ind Pharm; 2017 Dec; 43(12):2055-2063. PubMed ID: 28845697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipid vesicle-based permeation assay and EpiSkin® in assessment of drug therapies destined for skin administration.
    Engesland A; Škalko-Basnet N; Flaten GE
    J Pharm Sci; 2015 Mar; 104(3):1119-27. PubMed ID: 25558045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a novel human stratum corneum model, as a tool in the optimization of drug formulations.
    Shakel Z; Nunes C; Costa Lima SA; Reis S
    Int J Pharm; 2019 Oct; 569():118571. PubMed ID: 31352050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucus-PVPA (mucus Phospholipid Vesicle-based Permeation Assay): An artificial permeability tool for drug screening and formulation development.
    Falavigna M; Klitgaard M; Brase C; Ternullo S; Škalko-Basnet N; Flaten GE
    Int J Pharm; 2018 Feb; 537(1-2):213-222. PubMed ID: 29288094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a biomimetic phospholipid vesicle-based permeation assay for the estimation of intestinal drug permeability.
    Naderkhani E; Isaksson J; Ryzhakov A; Flaten GE
    J Pharm Sci; 2014 Jun; 103(6):1882-90. PubMed ID: 24665049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel in vitro percutaneous penetration model: evaluation of barrier properties with p-aminobenzoic acid and two of its derivatives.
    de Jager M; Groenink W; Bielsa i Guivernau R; Andersson E; Angelova N; Ponec M; Bouwstra J
    Pharm Res; 2006 May; 23(5):951-60. PubMed ID: 16715385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes for (trans)dermal drug delivery: the skin-PVPA as a novel in vitro stratum corneum model in formulation development.
    Palac Z; Engesland A; Flaten GE; Škalko-Basnet N; Filipović-Grčić J; Vanić Ž
    J Liposome Res; 2014 Dec; 24(4):313-22. PubMed ID: 24646434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a novel human stratum corneum mimetic phospholipid -vesicle-based permeation assay models for
    Qian Y; Wei X; Wang Y; Yin S; Chen J; Dong J
    Drug Dev Ind Pharm; 2024 May; 50(5):410-419. PubMed ID: 38497274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeability and lipid organization of a novel psoriasis stratum corneum substitute.
    Basse LH; Groen D; Bouwstra JA
    Int J Pharm; 2013 Nov; 457(1):275-82. PubMed ID: 24036087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labelled vesicles.
    Fresta M; Puglisi G
    J Drug Target; 1996; 4(2):95-101. PubMed ID: 8894969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomes and niosomes as topical drug delivery systems.
    Choi MJ; Maibach HI
    Skin Pharmacol Physiol; 2005; 18(5):209-19. PubMed ID: 16015019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomes and skin: from drug delivery to model membranes.
    El Maghraby GM; Barry BW; Williams AC
    Eur J Pharm Sci; 2008 Aug; 34(4-5):203-22. PubMed ID: 18572392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological effect of lipid carriers on permeation of lidocaine hydrochloride through lipid membranes.
    Shim J; Kim MJ; Kim HK; Kim DH; Oh SG; Ko SY; Jang HG; Kim JW
    Int J Pharm; 2010 Mar; 388(1-2):251-6. PubMed ID: 20060459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of rabbit ear skin as a skin model for in vitro transdermal permeation experiments: histology, lipid composition and permeability.
    Nicoli S; Padula C; Aversa V; Vietti B; Wertz PW; Millet A; Falson F; Govoni P; Santi P
    Skin Pharmacol Physiol; 2008; 21(4):218-26. PubMed ID: 18509256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a liposome-based artificial skin membrane for in vitro permeation studies using Franz diffusion cell device.
    Zhang H; Zhu X; Shen J; Xu H; Ma M; Gu W; Jiang Q; Chen J; Duan J
    J Liposome Res; 2017 Dec; 27(4):302-311. PubMed ID: 27581379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved permeability of acyclovir: optimization of mucoadhesive liposomes using the phospholipid vesicle-based permeation assay.
    Naderkhani E; Erber A; Škalko-Basnet N; Flaten GE
    J Pharm Sci; 2014 Feb; 103(2):661-8. PubMed ID: 24395733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a model membrane system using stratum corneum lipids for estimation of drug skin permeability.
    Matsuzaki K; Imaoka T; Asano M; Miyajima K
    Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):575-9. PubMed ID: 8477512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.